New targets in triple-negative breast cancer

Nat Rev Cancer. 2021 Dec;21(12):744. doi: 10.1038/s41568-021-00415-4.

Authors

Robert L Copeland¹, Yasmine Kanaan²

Affiliations

¹ Department of Pharmacology, College of Medicine and Howard University Cancer Center, Howard University, Washington DC, USA. rlcopeland@howard.edu.
² Department of Microbiology, College of Medicine and Howard University Cancer Center, Howard University, Washington DC, USA. ymkanaan@howard.edu.

PMID: 34621048
DOI: 10.1038/s41568-021-00415-4

No abstract available

Publication types

Comment

MeSH terms

Breast Neoplasms*
Female
Humans
MicroRNAs*
Receptor, ErbB-2 / genetics
Triple Negative Breast Neoplasms* / drug therapy
Triple Negative Breast Neoplasms* / genetics

Substances

MicroRNAs
Receptor, ErbB-2